RecallRadar

FDA Drug recall D-0710-2021

MORPHINE-BUPIVACAINE PF INJECTABLE 21 mL, 22 mL, 23 mL, 41 mL and 43 mL syringes in various strengths: a) 20MG/ML-40MG/ML, b) 15MG-30MG/ML,…

On 2021-08-18 the FDA classified a Class I recall of MORPHINE-BUPIVACAINE PF INJECTABLE 21 mL, 22 mL, 23 mL, 41 mL and 43 mL syringes in various strengths: a) 20MG/ML-40MG/ML, b) 15MG-30MG/ML,… by Med Shop Total Care, citing non-Sterility.

Read the official FDA Drug notice

AgencyFDA Drug
Recall numberD-0710-2021
ClassificationClass I
Statusterminated
Initiated2020-10-05
Published2021-08-18
Last updated2026-09-13 11:52 UTC
CompanyMed Shop Total Care
DistributionPR, TX

Product

MORPHINE-BUPIVACAINE PF INJECTABLE 21 mL, 22 mL, 23 mL, 41 mL and 43 mL syringes in various strengths: a) 20MG/ML-40MG/ML, b) 15MG-30MG/ML, c) 5MG/ML-20MG/ML, d) 2MG-30MG/ML, e) 20MG-5MG/ML, f) 15MG-5MG/ML, g) 5MG-2MG/ML, h) 5MG-11MG/ML, i) 20MG-6MG/ML, j) 10MG-10MG/ML, k) 6MG-4.8MG/ML, l) 30MG-10MG/ML, m) 5MG-4MG/ML, n) 10MG/ML-20MG/ML, o) 40MG-5MG/ML, p) 20MG-20MG/ML, q) 30MG-20MG/ML, Rx only, Med Shop Total Care 470 East Loop 281 Longview, TX 75605

Reason

Non-Sterility

Identifiers

code_info
Lot #: a) 09282020@62, BUD 10/27/2020, 09302020@25, BUD 10/29/2020, b) 09292020@56, c) 09292020@58, d)09292020@60, e) 0…Lot #: a) 09282020@62, BUD 10/27/2020, 09302020@25, BUD 10/29/2020, b) 09292020@56, c) 09292020@58, d)09292020@60, e) 09292020@66, 09292020@73, f) 09292020@70, g) 09292020@71, h) 09292020@77, i) 09302020@20 j) 09302020@33, k) 09302020@48, l) 09302020@61, m) 09302020@66, n) 09302020@70, o) 09302020@26, BUD 10/29/2020, p) 10012020@8, q) 10022020@20, BUD 10/30/2020

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.

Source

Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0710-2021%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.